Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME
Estimated value
£268k
Awarded value
£268k
Suppliers
1
Lots
1
Published
24 Dec 2024
Description
The "Pharmacogenetics as a Service" component of the PROGRESS Programme aims to develop a digital solution which allows the persistence and messaging of pharmacogenetic data. This will be performed in the context of an initial pilot as part of the wider PROGRESS Programme, but any solution should have the potential to scale across the NHS.
Scope
- Reference
- C316258-MFT24-0039
- Total value
- £268,488 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 17 Dec 2024 to 30 Mar 2026
- CPV classifications
- 48000000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 23 Oct 2024, 11:00 am
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£268k
Award date
22 Oct 2024
Contract start
17 Dec 2024
Contract end
30 Mar 2026
Awarded suppliers· 1 supplier
Awarded 22 Oct 2024 · Contract period 17 Dec 2024 — 30 Mar 2026
Other contracts from Manchester University NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to Clinical Architecture Limited· 2
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| G Cloud 15 | contract | — | 24 Jul 2026 |
| Pharmacogenomics as a Service - NW GMSA PROGRESS PROGRAMME | contract | £120k | 11 May 2023 |